Global Apheresis Equipment Market Size By Type (Centrifugation, Membrane Filtration), By Application (Platelets, RBC), By Region, And Segment Forecasts, 2023 to 2032

The Global Apheresis Equipment Market was valued at USD 2.4 billion in 2023 and is expected to reach USD 4.5 billion by 2031, growing at a CAGR of 8.2% during the forecast period from 2023 to 2031. The market growth is driven by the increasing prevalence of chronic diseases such as cancer, autoimmune disorders, and hematological conditions, alongside a rising number of surgical procedures requiring blood component separation. Technological advancements in apheresis systems and a growing preference for automated processes in blood donation centers and hospitals further contribute to market expansion.

Drivers

Increasing Incidence of Chronic Diseases

The global surge in conditions such as leukemia, lymphoma, and multiple myeloma has significantly boosted the demand for apheresis procedures, which are crucial for collecting specific blood components.

Advancements in Apheresis Technologies

Modern apheresis equipment offers features like closed-system operation, enhanced safety, and reduced procedural time. These technological innovations are improving procedure efficiency and outcomes, leading to higher adoption rates.

Growing Demand for Blood Components

The need for individual blood components (plasma, platelets, red blood cells) has grown across therapeutic and research settings, accelerating the use of apheresis systems.

Restraints

High Cost of Equipment and Procedures

The sophisticated nature of apheresis systems entails high acquisition and maintenance costs, which can be a barrier, especially in developing countries and small healthcare setups.

Risk of Complications

Despite being minimally invasive, apheresis procedures may pose risks such as citrate toxicity, hypotension, or infection, potentially discouraging patient compliance.

Opportunity

Expansion in Emerging Markets

Rapid improvements in healthcare infrastructure and increasing awareness of blood disorders in Asia-Pacific and Latin America offer untapped growth potential for apheresis equipment manufacturers.

Rising Demand for Plasma-Derived Medicines

The increasing utilization of plasma in immunoglobulin and albumin production is promoting investments in plasmapheresis systems globally.

Market by System Type Insights

Based on system type, Automated Apheresis Equipment led the market in 2023 due to its precision, reduced manual intervention, and suitability for both donor and therapeutic applications. This segment is expected to continue its dominance owing to growing demand for rapid and safe blood separation processes in hospitals and donation centers.

Market by End-use Insights

In terms of end-use, the Hospitals & Specialty Clinics segment held the largest market share in 2023. Hospitals remain the primary centers for apheresis treatments for chronic illnesses and transplantation. Meanwhile, the Blood Collection Centers segment is expected to witness rapid growth, driven by rising blood donation drives and need for specific component extraction.

Market by Regional Insights

North America dominated the market in 2023, owing to its well-established healthcare system, high adoption of advanced technologies, and supportive reimbursement policies. Asia-Pacific is forecasted to grow at the fastest pace due to increasing healthcare investments, rising chronic disease burden, and growing awareness about apheresis procedures in countries like India and China.

Competitive Scenario

Key players in the Global Apheresis Equipment Market include:

Terumo BCT, Inc.

Fresenius Kabi AG

Haemonetics Corporation

Asahi Kasei Medical Co., Ltd.

Baxter International Inc.

B. Braun Melsungen AG

Kawasumi Laboratories, Inc.

These companies are actively investing in R&D, introducing AI-integrated apheresis systems, and expanding their global presence through strategic partnerships.

Scope of Work – Global Apheresis Equipment Market

Report Metric Details

Market Size (2023) USD 2.4 Billion

Projected Market Size (2031) USD 4.5 Billion

CAGR (2023-2031) 8.2%

Market Segments System Type (Automated, Manual), End-use (Hospitals, Clinics, Blood Centers)

Growth Drivers Rise in chronic diseases, technological advancements, blood component demand

Opportunities Emerging markets, plasma-derived product demand

Key Market Developments

2023: Haemonetics launched a new generation of plasma collection devices featuring advanced user interfaces and automated flow control systems.

2024: Terumo BCT announced a partnership with a leading biotechnology firm to integrate AI-based decision support tools into its apheresis platforms.

2025: Fresenius Kabi expanded its manufacturing plant in Europe to meet growing demand for therapeutic apheresis devices across the EU.

FAQs

1) What is the current market size of the Global Apheresis Equipment Market?

The market was valued at USD 2.4 billion in 2023.

2) What is the major growth driver of the Global Apheresis Equipment Market?

The rising prevalence of chronic and autoimmune diseases is a primary driver.

3) Which is the largest region during the forecast period in the Global Apheresis Equipment Market?

North America is the largest region due to high adoption of advanced healthcare technologies.

4) Which segment accounted for the largest market share in the Global Apheresis Equipment Market?

The Automated Apheresis Equipment segment led the market in 2023.

5) Who are the key market players in the Global Apheresis Equipment Market?

Major players include Terumo BCT, Fresenius Kabi, Haemonetics, Asahi Kasei Medical, and Baxter International.